Hangyu Li
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 2
- MicroRNA in disease regulation 2
-
- Extracellular vesicles in disease 3
- RNA modifications and cancer 2
-
- Ferroptosis and cancer prognosis 2
-
- Immune cells in cancer 2
-
- Industrial Vision Systems and Defect Detection 2
-
- Berberine and alkaloids research 1
- Partner nations
- ChinaUnited KingdomAustralia
In The Last Decade
Hangyu Li
10 papers receiving 690 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Cancer Research 389
- Molecular Biology 525
- Cell Biology 109
- Pulmonary and Respiratory Medicine 122
- Immunology 75
Countries citing papers authored by Hangyu Li
This map shows the geographic impact of Hangyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangyu Li more than expected).
Fields of papers citing papers by Hangyu Li
This network shows the impact of papers produced by Hangyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangyu Li. The network helps show where Hangyu Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hangyu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 8 | |
| 6 | Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applicationsbreakdown → | 2022 | 144 |
| 7 | 2022 | 46 | |
| 8 | 2021 | 50 | |
| 9 | 2021 | 69 | |
| 10 | 2020 | 77 | |
| 11 | 2018 | 127 | |
| 12 | 2017 | 174 |
About Hangyu Li
Hangyu Li is a scholar working on Internal Medicine, Cancer Research and Industrial and Manufacturing Engineering, having authored 12 papers that have together received 697 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (3 papers), RNA modifications and cancer (2 papers), Immune cells in cancer (2 papers), Cancer, Lipids, and Metabolism (2 papers), Industrial Vision Systems and Defect Detection (2 papers), MicroRNA in disease regulation (2 papers), Ferroptosis and cancer prognosis (2 papers) and Berberine and alkaloids research (1 paper). The work is most often cited by research in Cancer Research (389 citations), Molecular Biology (525 citations) and Cell Biology (109 citations). Hangyu Li has collaborated with scholars based in China, United Kingdom and Australia. Frequent co-authors include Liang Yang, Shibo Wei, Xueqiang Peng, Xiaodong Zhang, Qing Fan, Mingyao Huang, Shuo Yang, Shilei Tang, Hongyuan Jin and Yingbo Ma. Their work appears in journals such as Molecular Cancer, Cancer Letters and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.